ETV7 antibody (C-Term)
Quick Overview for ETV7 antibody (C-Term) (ABIN6736601)
Target
See all ETV7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Human ETV7
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human (100%) Dog (81%).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human ETV7 (Q9Y603, NP_057219). Percent identity by BLAST analysis: Human, Gorilla (100%), Gibbon, Marmoset (92%), Elephant, Panda, Dog (81%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: WB (0.06 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- ETV7 (Ets Variant 7 (ETV7))
-
Alternative Name
- TEL-2 / ETV7
-
Background
-
Name/Gene ID: ETV7
Synonyms: ETV7, ETS translocation variant 7, Ets variant 7, TELB, TEL2 oncogene, Transcription factor ETV7, TEL-2, TEL2, TREF, ETS-related protein Tel2, Tel-related Ets factor, Transcription factor Tel-2 -
Gene ID
- 51513
-
NCBI Accession
- NP_057219
-
UniProt
- Q9Y603
Target
-